Formulation and Evaluation of a Sustained-Release Tablets of Metformin Hydrochloride Using Hydrophilic Synthetic and Hydrophobic Natural Polymers

Metformin hydrochloride has relatively short plasma half-life, low absolute bioavailability. The need for the administration two to three times a day when larger doses are required can decrease patient compliance. Sustained release formulation that would maintain plasma level for 8-12 h might be suf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadher, K. J., Kakde, R. B., Umekar, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267306/
https://www.ncbi.nlm.nih.gov/pubmed/22303065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267306/
https://www.ncbi.nlm.nih.gov/pubmed/22303065

Ejemplares similares